1-4 of 4
Raymond Cruz, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Thrombocytopenia Predicts for Poor Survival In Patients with Lower Risk Myelodysplastic Syndromes (MDS)

Raymond Cruz, MD, Naomi Galili, Ph.D., Ghulam Sajjad Khan, MD, Azra Raza, MD
Journal: Blood
Blood (2010) 116 (21): 4021.
https://doi.org/10.1182/blood.V116.21.4021.4021
Published: 2010
Journal Articles

Emergence of Rituximab-Fludarabine Resistance Is Associated with Changes in CD20 Antigen Expression and Improved Response to Almetuzumab Therapy in Patients with Chronic Lymphocytic Leukemia (CLL).

Umeer Ashraf, MD, Anjana N. Elefante, PharmD, Raymond Cruz, MD, Paul K. Wallace, PhD, Myron S. Czuczman, MD, Francisco J. Hernandez-llizaliturri, MD
Journal: Blood
Blood (2007) 110 (11): 2054.
https://doi.org/10.1182/blood.V110.11.2054.2054
Published: 2007
Journal Articles

Lenalidomide (Revlimid®) Enhances Monoclonal Antibody-Associated Anti-Tumor Activity Against Rituximab-Sensitive and Rituximab-Resistant B-Cell Lymphoma Cell Lines.

Nishitha Reddy, MD, Raymond Cruz, MD, Francisco Hernandez-Ilizaliturri, MD, Joy Knight, BS, Myron S. Czuczman, MD
Journal: Blood
Blood (2006) 108 (11): 2522.
https://doi.org/10.1182/blood.V108.11.2522.2522
Published: 2006
Journal Articles

Dexamethasone (D), High Dose Ara-C (HA) and Carboplatin (DHAC) with or without Rituximab (R) Is an Effective Salvage Regimen for Patients with Relapsed/Refractory B-Cell Lymphoma in Preparation for Autologous Stem Cell Transplantation.

Raymond Cruz, MD, Myron S. Czuczman, MD, Francisco Hernandez, MD, Ajay Kanra, MD, Swaminathan Padmanabhan, MD
Journal: Blood
Blood (2006) 108 (11): 4730.
https://doi.org/10.1182/blood.V108.11.4730.4730
Published: 2006